Abstract

Hypertension is a chronic disease that requires regular therapy to control blood pressure. The cost of treating hypertension can be measured by using a cost-of-illness analysis. The purpose of this study was to find out the total cost of treating hypertensive outpatients participating in BPJS (universal coverage). Who treated with Captopril for one year at the Banyuanyar primary healthcare centre in Sampang Regency. In a study by Baroroh and Sari (2017), hypertension treatment requires a large cost because it is carried out in a long time. Method this study used a non-random sampling technique with a purposive sampling method with criteria that have been determined by the researcher. This research conducted at Banyuanyar Health Center with total sample 40 people. The instrument used was a structured interview which was previously tested for content validity. The data were analyze by using Microsoft® Excel. The result of this study showed that the cost-of-illness for hypertensive patients for one year was Rp 36.140 to Rp 2.528.000. The total range of direct medical costs was Rp 36.140 to Rp 368.000 per patient, the range of direct non-medical costs was Rp 0 to Rp 360.000 per patient, and the range of indirect costs is Rp. 0 to Rp. 1.800.000 per patient. The difference in cost value range was influenced by the frequency of patient visits. Cheaper costs indicated lower frequency of patient visits and disorderly patient compliance, therefore the therapeutic effects achieved were less good. However, more expensive cost indicated higher frequency of patient visits and orderly patient compliance, and be able to achieved better the therapeutic effects. The effect of less maximum therapy is known with often patients buying drugs outside the primary healthcare centre caused by uncontrolled hypertension disease so that it can trigger very high blood pressure at any time, this is related to the nonroutine of patients in carrying out treatment in the primary healthcare centre.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.